Baluch Khoso
SEC CIK 1686223 · EDGAR
BoughtSold
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-30 16:46 | 2026-06-26 | PCSA | Processa Pharmaceuticals, Inc. | Baluch Khoso | Dir | M - OptEx | — | +203 | 2,528 | +9% | — |
| 2026-04-01 17:06 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Baluch Khoso | Dir | P - Purchase | $2.54 | +2,269 | 2,325 | +4,052% | +$5,752 | |
| D | 2025-08-13 | 2025-08-11 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | P - Purchase | — | +11.8K | 52.5K | +29% | — |
| 2025-07-17 | 2025-07-15 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | A - Grant | $0.00 | +17.0K | 40.8K | +72% | $0 | |
| 2024-12-04 | 2024-12-02 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | S - Sale | $2.07 | -1,250 | 23.8K | -5% | -$2,588 | |
| 2024-08-19 | 2024-08-15 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | A - Grant | $0.00 | +23.5K | 38.4K | +158% | $0 | |
| 2024-06-11 | 2024-06-09 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | F - Tax | $1.06 | -125 | 14.9K | -0.8% | -$132.50 | |
| M | 2024-01-02 | 2023-12-28+ | LGVN | Longeveron Inc. | Baluch Khoso | Dir | P - Purchase | $1.42 | +10.0K | 6,678 | New | +$14.2K |
| D | 2023-07-24 | 2023-06-27 | PCSA | Processa Pharmaceuticals, Inc. | Baluch Khoso | Dir | M - OptEx | — | +15.5K | 28.0K | +124% | — |
| 2023-06-12 | 2023-06-09 | LGVN | Longeveron Inc. | Baluch Khoso | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| 2023-02-10 | 2023-02-09 | PCSA | Processa Pharmaceuticals, Inc. | Baluch Khoso | Dir | A - Grant | $0.8 | +12.5K | 12.5K | New | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations